Evommune, Inc. EVMN
- EVO756 — Chronic Inducible Urticaria Phase 2
- EVO756 — Atopic Dermatitis Phase 2
- EVO756 — Migraine Phase 2
MRGPRX2 (2 companies · 5 programs)
Companies with an active program directed at MRGPRX2.
Arcus Biosciences, Inc. RCUS
- AB102 — Atopic Dermatitis Preclinical
- AB102 — Chronic Spontaneous Urticaria Preclinical